Bio Special BioInvest
Qritive (www.qritive.com), a leading healthcare AI startup has announced that they have raised $7.5M in a funding round led by MassMutual Ventures, support...
January 09, 2023 | News
Under the terms of the Rights Offering, Parnell is extending the expiration date to Wednesday, January 11, 2023 at 5:00 PM (Eastern Time)&nb...
January 09, 2023 | News
BioVersys AG, a privately held clinical stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for life-th...
January 06, 2023 | News
The Notes are currently being offered and sold only to persons who are reasonably qualified institutional purchasers within the meaning of Rule 144A under ...
December 19, 2022 | News
The dividend is payable on March 10, 2023 to shareholders of record at the close of business on Feb. 15, 2023. Lilly unites caring with ...
December 13, 2022 | News
This quarterly declaration is consistent with the dividend announcement made by the company in May 2022. Medtronic is a constituent of the S&P 500...
December 09, 2022 | News
BICO Group is a pioneer and leading provider of instruments and consumables for bioprinting, bioscience and bioautomation applications in the life scienc...
December 08, 2022 | News
Since the company’s inception in 2013, BRIM has successfully developed several platform technologies, including the regenerative peptide technology (...
December 05, 2022 | News
Fourth-quarter fiscal year 2022 Revenue of $1.85 billion represents 11% reported growth year-over-year; and up 17% on a core(1) basis. GAAP net in...
November 24, 2022 | News
Fujifilm’s fifth media manufacturing site to be operated by FUJIFILM Irvine Scientific Triples the company’s current capacity for liquid cel...
November 23, 2022 | News
The Notes were offered as part of the financing for the proposed spin-off of GE HealthCare from GE (the “Spin-Off”), which is expected to be co...
November 23, 2022 | News
Cyclica Inc., a neo-biotech that is unlocking the protein universe to discover the medicines of tomorrow, is developing new, non-hormonal contraceptives fo...
November 15, 2022 | News
Results of the third quarter of 2022 Group net sales rise by 16.8% to € 5.8 billion Strong organic sales growth of 7.1%, driven by the &...
November 14, 2022 | News
Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potent...
November 08, 2022 | News
Most Read
Bio Jobs
News
Editor Picks